Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

HCW Biologics Says If No Additional Financings Occur After Date Of Issuance, We Believe Relevant Conditions That Brought About Substantial Doubt Can Be Alleviated If We Implement Plan That Includes Certain Adjustments To Strategic And Operating Plans, Such As Cutting Back On Number Of Investigative Studies And Phase 2 Clinical Trials We Initiate; Reducing Salaries And Other Spending, And Limiting Amount Of Cash Used To Reduce Accounts Payable, As Well As Other Adjustments To Alleviate Substantial Doubt

Author: Benzinga Newsdesk | April 01, 2024 04:19pm

Posted In: HCWB